Antibodies! Ep. 3: Live from Antibody Engineering & Therapeutics, San Diego, USA

Recorded live at Antibody Engineering & Therapeutics in San Diego, Episode 3 of Antibodies! brings together leading voices from across the antibody discovery and development community for a series of conversations on some of the field’s most important challenges and opportunities. Hosted by Jonathan Davis, PhD, Founder of Creative Antibodies, this special conference edition features discussions on target discovery, tumor specificity, bispecific and trispecific antibodies, intracellular targets, antibody developability, Fc effector functions, nanobody discovery, and the growing role of artificial intelligence in antibody research. Featured guests include: Katherine Harris, PhD, Chief Development, Rondo Therapeutics; President, The Antibody Society Bryan Glaser, PhD, Senior Vice President of Business Development Invenra Bassil Dahiyat, PhD, President & Chief Executive Officer, Director, Xencor Jay M. Bhatt, Principal Scientist, Johnson & Johnson Innovative Medicine Shashi Jatiani, PhD, Director of Strategic Partnerships, SeromYx Systems Brandon DeKosky, PhD Associate Professor at MIT and The Ragon Institute/MGH Chris Szent Gyorgyi, PhD From emerging antibody formats and next generation targeting strategies to AI enabled discovery and developability assessment, this episode offers a snapshot of the ideas shaping the future of antibody therapeutics.